STLN
- Analyst Upgrades
Lake Street Maintains Buy on Starling Oncology, Lowers Price Target to $8
Lake Street maintains Starling Oncology with a Buy and lowers the price target from $10 to $8. ...
- Analyst Upgrades
B. Riley Securities Reiterates Buy on Starling Oncology, Lowers Price Target to $10
B. Riley Securities analyst Yuan Zhi reiterates Starling Oncology with a Buy and lowers the price target from $11 to $10. ...
- Analyst Upgrades
BTIG Maintains Buy on Starling Oncology, Raises Price Target to $10
BTIG analyst David Larsen maintains Starling Oncology with a Buy and raises the price target from $9 to $10. ...
- GlobeNewswire
Starling Oncology Reports Third Quarter 2026 Financial Results and Updates Full-Year 2026 Guidance
CERRITOS, Calif., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Starling Oncology, Inc. (NASDAQ:STLN) ("STLN" or the "Company"), one of the largest value-based community oncology groups in the United States, today ...
- GlobeNewswire
Starling Oncology Announces Third Quarter 2026 Earnings Release Date and Conference Call
CERRITOS, Calif., Oct. 26, 2026 (GLOBE NEWSWIRE) -- Starling Oncology, Inc. ("STLN") (NASDAQ:STLN) a pioneer in value-based community oncology care, today announced that the company will release its third ...
- Analyst Upgrades
Needham Maintains Buy on Starling Oncology, Raises Price Target to $9
Needham analyst Matthew Shea maintains Starling Oncology with a Buy and raises the price target from $7 to $9. ...
- GlobeNewswire
Starling Oncology to Participate in Wells Fargo Healthcare Conference
CERRITOS, Calif., Aug. 24, 2026 (GLOBE NEWSWIRE) -- Starling Oncology™, Inc. (NASDAQ:STLN), ("STLN" or the "Company"), one of the largest value-based community oncology groups in the United States, ...
- GlobeNewswire
Starling Oncology Launches Starling Nexus™, a Technology Platform Built to Optimize Oncology Provider Engagement and Accelerate High-Quality Care at Scale
CERRITOS, Calif., Aug. 17, 2026 (GLOBE NEWSWIRE) -- Starling Oncology™ Inc. (NASDAQ:STLN), ("STLN" or the "Company"), one of the largest value-based community oncology groups in the United States, ...
- GlobeNewswire
Starling Oncology Reports Second Quarter 2026 Financial Results and Updates Full-Year 2026 Guidance
CERRITOS, Calif., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Starling Oncology, Inc. (NASDAQ:STLN) ("STLN" or the "Company"), one of the largest value-based community oncology groups in the United States, today ...
- GlobeNewswire
The Oncology Institute Rebrands as Starling Oncology
CERRITOS, Calif., Aug. 03, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. ("TOI" or "the Company"), one of the largest value-based oncology groups in the United States, announced today that it ...